You'd think the emergence of a fatal disease—especially one that can be spread without physical contact—would be a big story. Yet a threatening new form of tuberculosis called extremely drug-resistant ...

The partnership leverages PPD’s pediatric clinical trial experience, regulatory knowledge, and site and pediatric patient networks, and Quotient’s expertise in pediatric formulation development, drug ...

Pharmaceutical Product Development (PPD) and Shin Nippon Biomedical Laboratories (SNBL) announced the formation of a joint venture in Japan to provide a range of clinical development services in that ...

An estimated 440 000 cases of multidrug-resistant tuberculosis (MDR TB) occurred worldwide in 2008 (3•6% of all TB cases that year), but only 7% of these cases were identified and treated. Extensively ...

An estimated 440 000 cases of multidrug-resistant tuberculosis (MDR TB) occurred worldwide in 2008 (3,6% of all TB cases that year), but only 7% of these cases were identified and treated. Extensively ...

PPD (Nasdaq: PPDI) will work with a Massachusetts firm to offer more services related to post-drug safety. , a pharmaceutical and contract research organization working with biotech and life-science ...

Tuberculosis, which kills around 1,000 people a day in India, has acquired a deadlier edge. A new entity, whic is ominously called Totally Drug-Resistant TB. While Iran first reported TDRTB cases ...